Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Marimed (MRMD) Other Gross PP&E Adjustments (2016 - 2025)

Marimed has reported Other Gross PP&E Adjustments over the past 13 years, most recently at $112.5 million for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 0.67% to $112.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $112.5 million through Dec 2025, up 0.67% year-over-year, with the annual reading at $112.5 million for FY2025, 0.67% up from the prior year.
  • Other Gross PP&E Adjustments was $112.5 million for Q4 2025 at Marimed, up from $108.0 million in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at $112.5 million in Q4 2025 and troughed at $48.0 million in Q1 2021.
  • The 5-year median for Other Gross PP&E Adjustments is $87.6 million (2023), against an average of $85.7 million.
  • Year-over-year, Other Gross PP&E Adjustments soared 51.82% in 2022 and then increased 0.67% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $53.5 million in 2021, then soared by 51.82% to $81.2 million in 2022, then increased by 24.12% to $100.7 million in 2023, then grew by 10.94% to $111.7 million in 2024, then rose by 0.67% to $112.5 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Other Gross PP&E Adjustments are $112.5 million (Q4 2025), $108.0 million (Q3 2025), and $106.3 million (Q2 2025).